United Therapeutics Corporation (UTHR)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	1,184,900	1,100,400	1,087,700	976,100	979,700	973,900	888,300	908,700	555,900	451,400	443,800	362,100	593,600	591,800	554,100	635,000	-187,600	-119,600	-153,400	-157,400
Revenue (ttm)	US$ in thousands	2,268,200	2,147,800	2,060,800	1,939,800	1,903,900	1,743,300	1,676,600	1,657,700	1,666,900	1,751,900	1,687,000	1,601,600	1,491,500	1,399,000	1,425,300	1,442,500	1,448,800	1,519,100	1,530,300	1,601,200
Operating profit margin		52.24%	51.23%	52.78%	50.32%	51.46%	55.87%	52.98%	54.82%	33.35%	25.77%	26.31%	22.61%	39.80%	42.30%	38.88%	44.02%	-12.95%	-7.87%	-10.02%	-9.83%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,184,900K ÷ $2,268,200K
= 52.24%

United Therapeutics Corp has demonstrated consistently strong operating profit margins over the past eight quarters. The company's operating profit margin has ranged from 49.27% to 52.36% during this period, indicating a stable and robust operating performance. The average operating profit margin over the eight quarters is approximately 50.55%. This high level of operating profit margin suggests that United Therapeutics Corp is effectively controlling its operating expenses and generating a significant amount of profit from its core business operations. The slight fluctuations in operating profit margin from quarter to quarter are relatively minor and do not detract from the overall strong performance of the company in this area.